Latest news

Insights

Top 10 Technologies Accelerating Drug Discovery

Executive Summary Drug discovery is undergoing one of the most significant technological transformations in pharmaceutical history. Traditional discovery processes have...
Regulatory

FDA Advisory Panel to Review Grail’s Galleri Multi-Cancer Blood Test in September

Grail said the U.S. Food and Drug Administration (FDA) plans to convene a meeting of outside experts on Sept....
Commercial

Actimed Reclaims Rights to Wasting Disease Drug; $126M Faraday Deal Dead

Actimed Therapeutics has regained worldwide rights to its muscle-wasting therapy S-oxprenolol, giving the company full control over the program...
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational restructuring as it concentrates its resources on the development of...
Regulatory

Takeda’s Orzeyful Approved as First Orexin Agonist for Narcolepsy Type 1

The U.S. Food and Drug Administration (FDA) has approved...
Commercial

The biggest pharmaceutical deal ever would be the “unlikely” AstraZeneca-BMS mega-merger

Word spread that two big pharma players, Bristol Myers...
Commercial

Supernus and Indivior Agree to Create CNS-Focused Company in All-Stock Merger

Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to combine in an all-stock merger that will create a central nervous...
Insights

From Data-Rich to Insight-Rich: Pharma’s Next Transformation

Executive Summary The pharmaceutical industry has become one of the most data-intensive industries in the world. Every stage of the pharmaceutical...
Commercial

Hinge Health to Buy Out Cylinder Health in a Deal Worth Over $100M

Hinge Health has agreed to acquire digital gastrointestinal care startup Cylinder Health as the company expands its platform beyond...
Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting...
Clinical

Merck’s Tulisokibart Misses Phase 2 Endpoint in SSc-ILD but Meets Goals in HS Trial

Merck & Co. has reported mixed clinical results for...
Insights

The New Competitive Advantage in Biopharma Isn’t Science Alone

Executive Summary For decades, scientific innovation has been the defining competitive advantage in biopharmaceuticals. Companies that discovered breakthrough molecules, developed novel...
Insights

Why Protocol Complexity Continues to Threaten Trial Success

Executive Summary Clinical trials remain the foundation of pharmaceutical innovation, but their increasing complexity has become one of the industry's...
Regulatory

FDA Grants Full Approval to Fabhalta for IgA Nephropathy

Novartis has received full approval from the U.S. Food and Drug Administration (FDA ) for Fabhalta to treat adults...
Commercial

Actimed Reclaims Rights to Wasting Disease Drug; $126M Faraday Deal Dead

Actimed Therapeutics has regained worldwide rights to its muscle-wasting...
Editorial Team -
Commercial

Minghui Announces $131 Pre-IPO Funding to Support JAK Inhibitor Launch

Minghui Pharmaceutical has raised $131 million during a funding...
Commercial

Valneva and Pfizer delay release schedule for Lyme disease vaccine

Pfizer and Valneva are delaying the regulatory filing of...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

Regulatory

Regulatory

FDA Advisory Panel to Review Grail’s Galleri Multi-Cancer Blood Test in September

Grail said the U.S. Food and Drug Administration (FDA)...
Commercial

Actimed Reclaims Rights to Wasting Disease Drug; $126M Faraday Deal Dead

Actimed Therapeutics has regained worldwide rights to its muscle-wasting...
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational...
Insights

What an Autonomous Clinical Trial Might Look Like by 2030

Executive Summary Clinical trials are undergoing one of the most...

Research & Development

Market Access

Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration...
Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Technologies Accelerating Drug Discovery

Executive Summary Drug discovery is undergoing one of the most...
Editorial Team -
Manufacturing

Novo Nordisk Sues Eli Lilly Over GLP-1 Drug Advertising Claims

Novo Nordisk has filed a lawsuit against Eli Lilly...
Editorial Team -
Commercial

Actimed Reclaims Rights to Wasting Disease Drug; $126M Faraday Deal Dead

Actimed Therapeutics has regained worldwide rights to its muscle-wasting...
Editorial Team -